DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers

Biochemistry. 2023 Mar 7;62(5):976-988. doi: 10.1021/acs.biochem.2c00581. Epub 2023 Feb 22.

Abstract

Tau aggregate-bearing lesions are pathological markers and potential mediators of tauopathic neurodegenerative diseases, including Alzheimer's disease. The molecular chaperone DJ-1 colocalizes with tau pathology in these disorders, but it has been unclear what functional link exists between them. In this study, we examined the consequences of tau/DJ-1 interaction as isolated proteins in vitro. When added to full-length 2N4R tau under aggregation-promoting conditions, DJ-1 inhibited both the rate and extent of filament formation in a concentration-dependent manner. Inhibitory activity was low affinity, did not require ATP, and was not affected by substituting oxidation incompetent missense mutation C106A for wild-type DJ-1. In contrast, missense mutations previously linked to familial Parkinson's disease and loss of α-synuclein chaperone activity, M26I and E64D, displayed diminished tau chaperone activity relative to wild-type DJ-1. Although DJ-1 directly bound the isolated microtubule-binding repeat region of tau protein, exposure of preformed tau seeds to DJ-1 did not diminish seeding activity in a biosensor cell model. These data reveal DJ-1 to be a holdase chaperone capable of engaging tau as a client in addition to α-synuclein. Our findings support a role for DJ-1 as part of an endogenous defense against the aggregation of these intrinsically disordered proteins.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Molecular Chaperones / genetics
  • Neurodegenerative Diseases*
  • Parkinson Disease* / metabolism
  • Protein Deglycase DJ-1 / genetics
  • alpha-Synuclein / chemistry
  • tau Proteins / genetics

Substances

  • alpha-Synuclein
  • tau Proteins
  • Molecular Chaperones
  • Protein Deglycase DJ-1